Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 18:13:886428.
doi: 10.3389/fmicb.2022.886428. eCollection 2022.

Comparative Genomics Revealed Fluoroquinolone Resistance Determinants and OmpF Deletion in Carbapenem-Resistant Escherichia coli

Affiliations

Comparative Genomics Revealed Fluoroquinolone Resistance Determinants and OmpF Deletion in Carbapenem-Resistant Escherichia coli

Wan-Ting Yang et al. Front Microbiol. .

Erratum in

Abstract

Escherichia coli (E. coli) is a major causative organism of complicated urinary tract infections, bloodstream infections, and pneumonia. With the widespread use of antimicrobial agents, the prevalence of carbapenem resistance in E. coli has been increasing with limited therapeutic options. Fluoroquinolone remains a choice in carbapenem-resistant E. coli (CREc) that were once susceptible to the drug. Despite robust studies on the fluoroquinolone-resistant mechanisms of E. coli, few studies focused specifically on the group of CREc. In this study, we used comparative genomics to identify the fluoroquinolone-resistant mechanisms of CREc and detected gyrA D87N mutation in all the fluoroquinolone-resistant and CREc. Moreover, to investigate the mechanism underlying non-carbapenemase-producing carbapenem-resistant E. coli, we targeted the complete genome sequences for in-depth analysis and found a deletion in OmpF (DEL264-269) that might contribute to carbapenem resistance, which has not been reported before. Further studies focusing on the impact of these mutations on the expression levels are warranted. We further investigate the MLST, serotype, fimH type, phylogroup, and clinical characteristics of the CREc. Combination analysis of clinical and genomic characteristics suggests the polyclonal and highly diverse nature of the CREc in Taiwan. This study provides an insight into the molecular epidemiology of CREc in Taiwan.

Keywords: Escherichia coli; carbapenem-resistant; carbapenemase; epidemiology; virulence; whole-genome sequencing.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
(A) Multiple sequence alignment of OmpF revealed deletion in 264-269. (B) Phylogenetic clusters in deleted OmpF.
Figure 2
Figure 2
Venn diagrams comparing virulence factors of bloodstream infections from abdominal origin or urologic origin. Five E. coli isolates from the urinary tract shared eight virulence factors, including gad, terC, traT, fyuA, irp2, iucC, iutA, and ompT. Five E. coli isolates from abdominal origin shared four virulence factors, including gad, terC, traT, and sitA. Bloodstream infection from both sources contained virulence factors of gad, terC, and traT. Venn diagrams were created by InteractiVenn (Heberle et al., 2015).
Figure 3
Figure 3
The reporting proportion of non-CP-CRE and carbapenemase among CREc/CNSEc (Rimrang et al., ; Del Franco et al., ; Lefebvre et al., ; Baran and Aksu, ; Dupont et al., ; Jeong et al., ; Sharma et al., ; Grundmann et al., ; Karlowsky et al., ; Marimuthu et al., ; Trepanier et al., ; Abd El Ghany et al., ; Dagher et al., ; Senchyna et al., ; Al-Farsi et al., ; Abid et al., ; Huang et al., ; Musila et al., ; Tickler et al., ; Yan et al., 2021).
Figure 4
Figure 4
Molecular resistance mechanisms in non-carbapenemase-producing carbapenem-resistant E. coli/carbapenem non-susceptible E.coli (non-CP-CREc /non-CP-CNEc) (Chia et al., ; Ma et al., ; Dupont et al., ; Ho et al., ; Dagher et al., ; Senchyna et al., ; Al-Farsi et al., ; Tian et al., 2020).

Similar articles

Cited by

References

    1. Abd El Ghany M., Sharaf H., Al-Agamy M. H., Shibl A., Hill-Cawthorne G. A., Hong P. Y. (2018). Genomic characterization of NDM-1 and 5, and OXA-181 carbapenemases in uropathogenic Escherichia coli isolates from Riyadh, Saudi Arabia. PLoS ONE. 13, e0201613. 10.1371/journal.pone.0201613 - DOI - PMC - PubMed
    1. Abid F. B., Tsui C. K. M., Doi Y., Deshmukh A., McElheny C. L., Bachman W. C., et al. . (2021). Molecular characterization of clinical carbapenem-resistant Enterobacterales from Qatar. Eur. J. Clin. Microbiol. Infect. Dis. 40, 1779–1785. 10.1007/s10096-021-04185-7 - DOI - PMC - PubMed
    1. Alcock B. P., Raphenya A. R., Lau T. T. Y., Tsang K. K., Bouchard M., Edalatmand A., et al. . (2019). CARD 2020: antibiotic resistome surveillance with the comprehensive antibiotic resistance database. Nucl. Acids Res. 48, D517–D525. 10.1093/nar/gkz935 - DOI - PMC - PubMed
    1. Al-Farsi H. M., Camporeale A., Ininbergs K., Al-Azri S., Al-Muharrmi Z., Al-Jardani A., et al. . (2020). Clinical and molecular characteristics of carbapenem non-susceptible Escherichia coli: a nationwide survey from Oman. PLoS ONE. 15, e0239924. 10.1371/journal.pone.0239924 - DOI - PMC - PubMed
    1. Alikhan N.-F., Zhou Z., Sergeant M. J., Achtman M. J. (2018). A genomic overview of the population structure of Salmonella. PLoS Genet. 14, e1007261. 10.1371/journal.pgen.1007261 - DOI - PMC - PubMed

LinkOut - more resources